REVIEW

Depression in multiple sclerosis: a review

R J Siegert and D A Abernethy

Department of Medicine, Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand

Correspondence to:
Correspondence to:
R J Siegert
Rehabilitation Teaching and Research Unit, Department of Medicine, Wellington School of Medicine, University of Otago, PO Box 7343, Wellington South, New Zealand; rsiegert{at}wnmeds.ac.nz

Several studies have reported high rates of depression in multiple sclerosis (MS) with a lifetime prevalence of 50% and an annual prevalence of 20% not uncommon. Concern about the potential of new drug treatments to exacerbate or precipitate depression in MS has led to increased interest in the relation between MS and depression. This review on MS and depression identifies the following key issues: How common is depression in people with MS? Is depression in MS associated with lesions in specific regions of the central nervous system? Is there an increased risk of suicide in MS? Is there a higher than expected incidence of anxiety disorders in MS? Are fatigue and depressed mood related in MS? Is there a relation between depression and cognitive impairment in MS? Which psychosocial variables affect the development of depression in MS? Does treatment with interferon increase the risk of depression? How effective are treatments for MS patients with depression? Each of these issues is briefly reviewed with critical commentary, and some priorities for future research are suggested.

Abbreviations: BDI, Beck Depression Inventory; CBT, cognitive behavioural therapy; CES-D, Centre for Epidemiological Studies’ Depression Scale; MS, multiple sclerosis; SSRI, selective serotonin reuptake inhibitor

Keywords: multiple sclerosis; depression

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Foley, J. F., Brandes, D. W. (2009). Redefining functionality and treatment efficacy in multiple sclerosis. Neurology 72: S1-S11 [Abstract] [Full Text]  
• Choi, J. H, Preuss, U. W (2009). Relapsing-remitting type multiple sclerosis with olfactory hallucinosis and secondary delusions. BMJ Case Reports 2009: bcr0220091554-bcr0220091554 [Abstract] [Full Text]  
• Lode, K, Bru, E, Klevan, G, Myhr, K., Nyland, H, Larsen, J. (2009). Depressive symptoms and coping in newly diagnosed patients with multiple sclerosis. Mult Scler 15: 638-643 [Abstract]  
• Julian, L., Vella, L, Frankel, D, Minden, S., Oksenberg, J., Mohr, D. (2009). ApoE alleles, depression and positive affect in multiple sclerosis. Mult Scler 15: 311-315 [Abstract]  
• Poder, K, Ghatavi, K, Fisk, J., Campbell, T., Kisely, S, Sarty, I, Stadnyk, K, Bhan, V (2009). Social anxiety in a multiple sclerosis clinic population. Mult Scler 15: 393-398 [Abstract]  
• Haussleiter, I. S., Brune, M., Juckel, G. (2009). Review: Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment. Therapeutic Advances in Neurological Disorders 2: 13-29 [Abstract]  
• Ehrensperger, M., Grether, A, Romer, G, Berres, M, Monsch, A., Kappos, L, Steck, B (2008). Neuropsychological dysfunction, depression, physical disability, and coping processes in families with a parent affected by multiple sclerosis. Mult Scler 14: 1106-1112 [Abstract]  
• Nilsson, P, Rorsman, I, Larsson, E., Norrving, B, Sandberg-Wollheim, M (2008). Cognitive dysfunction 24-31 years after isolated optic neuritis. Mult Scler 14: 913-918 [Abstract]  
• Wynia, K, Middel, B, van Dijk, J., De Keyser, J., Reijneveld, S. (2008). The impact of disabilities on quality of life in people with multiple sclerosis. Mult Scler 14: 972-980 [Abstract]  
• Koch, M, Uyttenboogaart, M, van Harten, A, Heerings, M, De Keyser, J (2008). Fatigue, depression and progression in multiple sclerosis. Mult Scler 14: 815-822 [Abstract]  
• Amato, M. P., Goretti, B., Ghezzi, A., Lori, S., Zipoli, V., Portaccio, E., Moiola, L., Falautano, M., De Caro, M. F., Lopez, M., Patti, F., Vecchio, R., Pozzilli, C., Bianchi, V., Roscio, M., Comi, G., Trojano, M., For the Multiple Sclerosis Study Group of the Ital, (2008). Cognitive and psychosocial features of childhood and juvenile MS. Neurology 70: 1891-1897 [Abstract] [Full Text]  
• Goverover, Y., Genova, H., Hillary, F., DeLuca, J. (2007). The relationship between neuropsychological measures and the Timed Instrumental Activities of Daily Living task in multiple sclerosis. Mult Scler 13: 636-644 [Abstract]  
• Vahter, L., Kreegipuu, M., Talvik, T., Gross-Paju, K. (2007). One question as a screening instrument for depression in people with multiple sclerosis. Clin Rehabil 21: 460-464 [Abstract]  
• Schilling, M., Brueckner-Totonji, C., Arolt, V., Baune, B. T. (2006). A Case of Multiple Sclerosis Masked by Depression and Diabetic Neuropathy. Psychosomatics 47: 361-363 [Full Text]  
• Dilley, M., Fleminger, S. (2006). Advances in neuropsychiatry: clinical implications. Adv. Psychiatr. Treat. 12: 23-34 [Abstract] [Full Text]